Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Lancet Microbe, The | journal | 5.392 Q1 | 42 | 194 | 397 | 4066 | 3371 | 164 | 8.42 | 20.96 | 49.22 | |
2 | Eurosurveillance | journal | 2.881 Q1 | 131 | 246 | 759 | 5591 | 5761 | 704 | 7.96 | 22.73 | 56.99 | |
3 | Emerging Microbes and Infections | journal | 2.316 Q1 | 94 | 248 | 807 | 10789 | 7054 | 668 | 7.83 | 43.50 | 43.75 | |
4 | PLoS Pathogens | journal | 2.223 Q1 | 246 | 648 | 2162 | 44202 | 12150 | 2144 | 5.44 | 68.21 | 43.73 | |
5 | mBio | journal | 2.028 Q1 | 168 | 698 | 2309 | 39533 | 12160 | 2257 | 4.78 | 56.64 | 44.56 | |
6 | Virus Evolution | journal | 1.986 Q1 | 41 | 84 | 320 | 5193 | 1636 | 320 | 5.16 | 61.82 | 38.68 | |
7 | Cellular Microbiology | journal | 1.145 Q2 | 157 | 12 | 268 | 704 | 889 | 257 | 2.90 | 58.67 | 53.09 | |
8 | Viruses | journal | 1.140 Q2 | 130 | 2444 | 6780 | 153367 | 27347 | 6634 | 3.89 | 62.75 | 47.44 | |
9 | Gut Pathogens | journal | 1.092 Q2 | 56 | 62 | 181 | 3611 | 871 | 177 | 4.43 | 58.24 | 37.42 | |
10 | Virology Journal | journal | 1.016 Q2 | 99 | 301 | 657 | 14994 | 2805 | 653 | 4.16 | 49.81 | 43.39 | |
11 | Microbial Cell | journal | 0.982 Q2 | 39 | 22 | 87 | 1644 | 362 | 86 | 3.73 | 74.73 | 47.37 | |
12 | Microorganisms | journal | 0.944 Q2 | 87 | 2997 | 7161 | 209049 | 33794 | 7040 | 4.33 | 69.75 | 47.74 | |
13 | Virology: Research and Treatment | journal | 0.932 Q2 | 13 | 0 | 1 | 0 | 6 | 1 | 0.00 | 0.00 | 0.00 | |
14 | Epidemics | journal | 0.927 Q2 | 53 | 70 | 218 | 3080 | 691 | 216 | 3.25 | 44.00 | 38.66 | |
15 | Current Research in Parasitology and Vector-Borne Diseases | journal | 0.919 Q2 | 11 | 44 | 92 | 2309 | 283 | 91 | 3.08 | 52.48 | 44.37 | |
16 | Tumour Virus Research | journal | 0.904 Q2 | 34 | 17 | 49 | 1333 | 208 | 47 | 4.94 | 78.41 | 43.14 | |
17 | AIDS Research and Therapy | journal | 0.872 Q2 | 49 | 89 | 234 | 3234 | 555 | 234 | 2.18 | 36.34 | 48.99 | |
18 | Retrovirology | journal | 0.845 Q2 | 98 | 16 | 107 | 1314 | 260 | 100 | 2.34 | 82.13 | 47.37 | |
19 | Journal of Virus Eradication | journal | 0.818 Q2 | 17 | 40 | 96 | 1826 | 225 | 81 | 1.92 | 45.65 | 47.20 | |
20 | Intervirology | journal | 0.556 Q3 | 68 | 14 | 72 | 818 | 182 | 69 | 2.91 | 58.43 | 52.63 | |
21 | Animal Diseases | journal | 0.529 Q3 | 6 | 39 | 57 | 2167 | 123 | 55 | 2.16 | 55.56 | 40.43 | |
22 | HIV/AIDS - Research and Palliative Care | journal | 0.527 Q3 | 32 | 64 | 253 | 2489 | 451 | 253 | 1.53 | 38.89 | 35.09 | |
23 | FEMS Microbes | journal | 0.519 Q3 | 8 | 24 | 56 | 1594 | 147 | 52 | 2.79 | 66.42 | 45.06 | |
24 | Journal of Clinical Virology Plus | journal | 0.467 Q3 | 8 | 44 | 113 | 1223 | 183 | 106 | 1.62 | 27.80 | 46.45 | |
25 | Journal of Infection in Developing Countries | journal | 0.453 Q3 | 61 | 251 | 807 | 8051 | 1356 | 794 | 1.44 | 32.08 | 46.91 | |
26 | Antiviral Chemistry and Chemotherapy | journal | 0.369 Q3 | 59 | 2 | 29 | 41 | 62 | 28 | 0.87 | 20.50 | 0.00 | |
27 | Acta Virologica | journal | 0.310 Q4 | 36 | 20 | 153 | 851 | 210 | 145 | 0.96 | 42.55 | 49.62 | |
28 | Advances in Virology | journal | 0.282 Q4 | 31 | 13 | 41 | 538 | 50 | 41 | 1.38 | 41.38 | 56.16 | |
29 | Infectious Diseases and Immunity | journal | 0.247 Q4 | 5 | 16 | 58 | 405 | 51 | 52 | 0.88 | 25.31 | 48.51 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®